BlackRock is the world’s largest asset manager, overseeing trillions in global investments across ETFs, mutual funds and alternative assets. Known for its iShares ETF platform and data-driven approach, the firm provides diversified investment solutions to institutions and individuals while shaping global financial markets through its scale, technology and research capabilities.

Here are stocks in which BlackRock bought a stake via a bulk deal

TD Power Systems

TD Power Systems is a leading manufacturer of AC generators and engineered turbines, serving power, industrial, and renewable sectors worldwide. Known for its high-efficiency designs and strong engineering capabilities, the company partners with global OEMs and continues to expand its presence through technology upgrades, export growth, and diversified applications.

With a market capitalisation of Rs 11,961.99 crore, the shares were trading at Rs 765.85 per share, increasing around 0.88 percent as compared to the previous closing price.

iShares Core MSCI Emerging Markets ETF owned and managed by BlackRock through its iShares division, has acquired 968,194 equity shares at an average price of Rs 759.08 apiece. The translation is valued at Rs 73.49 crore.

ACC

ACC is one of India’s most established cement producers, known for its premium quality cement, nationwide distribution, and focus on sustainability. With modern plants, advanced R&D, and a rich legacy under the Adani Group, ACC supports major infrastructure, housing, and industrial projects while steadily strengthening capacity, efficiency, and green initiatives.

With a market capitalisation of Rs 35,070.21 crore, the shares were trading at Rs 1,867.55 per share, decreasing around 4.39 percent as compared to the previous closing price.

iShares Core MSCI Emerging Markets ETF  owned and managed by BlackRock through its iShares division, has acquired 982,442 equity shares at an average price of Rs 1,911.86 apiece. The translation is valued at Rs 187.82 crore.

Acutaas Chemicals

Acutaas Chemicals is an emerging speciality chemicals player focused on value-added formulations for pharmaceuticals, agrochemicals, and industrial applications. With an emphasis on innovation, custom synthesis, and quality compliance, the company is expanding its product portfolio and customer base, aiming to scale operations and capture opportunities in India’s fast-growing speciality chemicals market.

With a market capitalisation of Rs 14,570.60 crore, the shares were trading at Rs 1,779.70 per share, decreasing around 5.04 percent as compared to the previous closing price.

iShares Core MSCI Emerging Markets ETF owned and managed by BlackRock through its iShares division, has acquired 530,290 equity shares at an average price of Rs 1,852.12 apiece. The translation is valued at Rs 98.20 crore.

Written by Abhishek Singh

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.